The effects of renin–angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial

Mostrar otras versiones (1)

INTRODUCTION AND OBJECTIVE: A recent outbreak of coronavirus disease 2019 (COVID-19) occurs in the worldwide. Angiotensin-converting enzyme 2 (ACE2) can mediate coronavirus entry into host cells. Therefore, renin–angiotensin system inhibitors (RASI) were suspected of contributing to the increase of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Haiming, Wu, Feng, Fan, Zhenyu, Cheng, Xin, Cheng, Jilin, Fan, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533685/
https://www.ncbi.nlm.nih.gov/pubmed/33043142
http://dx.doi.org/10.1016/j.medcle.2020.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533685/
https://www.ncbi.nlm.nih.gov/pubmed/33043142
http://dx.doi.org/10.1016/j.medcle.2020.06.007

Ejemplares similares